Effect of Non-Statin Lipid-Lowering Therapy on Hepatic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review

Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are significant health concerns affecting a large segment of the population and are known to be associated with adverse cardiovascular outcomes. As a result, various lipid-low...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Walter Masson, Leandro Barbagelata, Juan Patricio Nogueira
Formato:	Artigo
Idioma:	Inglês
Publicado em:	The Korean Society of Lipid and Atherosclerosis 2025-09-01
Colecção:	Journal of Lipid and Atherosclerosis
Assuntos:	non-alcoholic fatty liver disease ezetimibe pcsk9 inhibitors eicosapentaenoic acid bempedoic acid
Acesso em linha:	https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2025.14.3.273&code=9992JLA&vmode=FULL
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!